Home | Login | Join | Sitemap | °ü¸®ÀÚ¿¡°Ô
  • ÇÐȸ ¼Ò°³
  • Á¶Á÷µµ
  • ÀÓ¿øÁø
  • ¿ª´ëÀÓ¿øÁø
  • ÆòÀÇ¿ø
  • ÇÐȸ ȸĢ
  • Çмú´ëȸ ¾È³»
  • °ü·Ã Çà»ç ¾È³»
  • Çмú´ëȸ ¿¬Çõ
  • Çмú´ëȸ ÀÚ·á
  • Åõ°í±ÔÁ¤
  • ³í¹®Åõ°í
  • ÇÐȸÁö °Ë»ö
  • ÇÐȸ ¼Ò½ÄÁö
  • ÀϹÝÀÎÀ» À§ÇÑ Áúȯ Á¤º¸
  • ±âŸÀÚ·á½Ç
  • º´¿ø ã±â
  • ÇÐȸ ¼Ò½Ä
  • ȸ¿ø °Ô½ÃÆÇ
  • ȸ¿ø ÀÚ·á½Ç
  • À§¿øȸ °ø°£
  • ȸ¿ø °Ë»ö
  • ÇÐȸ ¾Ù¹ü
Åõ°í±ÔÁ¤
³í¹®Åõ°í
ÇÐȸÁö °Ë»ö
- ÇÐȸÁö »ó¼¼°Ë»ö
- ÇÐȸÁö ±ÇÈ£º°°Ë»ö
ÇÐȸ ¼Ò½ÄÁö
HOME > °£Ç๰ > ÇÐȸÁö °Ë»ö
Korean Journal of Neuromuscular Disorders ; 1 : 51 - 57, June 2009
Clinical Diagnosis of Neuromuscular Junction Disorders
Down
In Soo Joo, MD
Department of Neurology, Ajou University College of Medicine, Suwon, Korea

The neuromuscular junction is a specialized myoneural synapse that is a target for a variety of disorders
including autoimmune origin. Although myasthenia gravis, the most common autoimmune neuromuscular
junction disorder, is characterized by weakness of muscles that increases with repetitive
use and improves with rest, disorders of the neuromuscular junction have a wide range of clinical
presentations. This frequently poses a diagnostic challenge to clinicians. The exact diagnosis of neuromuscular
junction disorders requires detailed history and physical examination, several pharmacological
methods, neurophysiologic testing, and serologic or immunologic tests. The clinical presentation
determines which diagnostic tests should be used in patients with these disorders.

KEYWORDS : Neuromuscular junction disorders, Diagnosis, Clinical presentation, Pharmacologic methods, Serologic tests

°Ô½Ã¹°¸ñ·ÏÀ» º¾´Ï´Ù.
(03163) ¼­¿ï Á¾·Î±¸ Àλ絿±æ 12, 1111È£ (Àλ絿, ´ëÀϺôµù)
TEL : 02-720-1594 E-mail : knmd1594@daum.net
Copyright©The Korean Society of Neuromuscular Disorders
TODAY 12 TOTAL 542624